Doxofylline

CAS No.	69975-86-6	Cat. No.	BCP12155
Name	Doxofylline
Synonyms	Ansimar; ABC-12-3; ABC-1213; ALT-07; DO-309; ABC 12 3; ABC 1213; ALT 07; DO 309; ABC12; 3; ABC1213; ALT07; DO309;
Formula	C11H14N4O4	M. Wt	266.26

Description	Doxofylline is a methylxanthine derivative with the presence of a dioxolane group in position 7. As a drug used in the treatment of asthma, doxofylline has shown similar efficacy to theophylline but with significantly fewer side effects in animal and human studies. In contrast with other xanthine derivatives, doxofylline does not significantly bind to adenosine alpha-1 or alpha-2 receptors and lacks stimulating effects. Decreased affinity for adenosine receptors may account for the better safety profile of doxofylline compared to theophylline. Unlike theophylline, doxofylline does not affect calcium influx and does not antagonize the actions of calcium channel blockers which could explain reduced cardiac adverse reactions associated with the drug. The anti-asthmatic effects of doxophylline are mediated by other mechanisms, primarily through inhibiting the activities of the phosphodiesterase (PDE) enzyme.
Pathways	Protease/Metabolic Enzyme GPCR/G Protein
Targets	Phosphodiesterase/PDE Adenosine Receptor

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.